The
biomaterials market is highly fragmented with players such as Royal DSM
(Netherlands), Wright Medical Technology, Inc. (U.S.), Corbion N.V.
(Netherlands), Zimmer Biomet Holdings, Inc. (U.S.), Bayer AG (Germany),
Carpenter Technology Corporation (U.S.), Covalon Technologies Ltd. (Canada),
Evonik Industries AG (Germany), BASF SE (Germany), Invibio Ltd. (U.K.),
Berkeley Advanced Biomaterials, Inc. (U.S.), CAM Bioceramics BV (Netherlands),
and Collagen Matrix, Inc. (U.S.).
Acquisitions, Agreements, collaborations, partnerships,
& Joint Venture, new product launches and expansion, are
major strategies adopted by the players to achieve growth in this market. Acquisitions
accounted for 23% of the total strategies adopted by the players in this market.
The key players that adopted this strategy include Royal DSM (Netherlands),
Wright Medical Technology, Inc. (U.S.), Corbion N.V. (Netherlands), Zimmer
Biomet Holdings, Inc. (U.S.), Heraeus Medical Components, Inc. (U.S), Collagen
Solutions plc (U.K.), Ceradyne, Inc. (U.S.), Bayer AG (Germany), Purac
Biomaterials (Netherlands), Hycail Finland Oy (Finland), DePuy Orthopaedics,
Inc. (U.S.), Orthovita, Inc. (U.S.), and Noble Biomaterials, Inc. (U.S.).
Agreements,
alliances, partnerships, joint ventures, and collaborations accounted for 19%
of the total number of key growth strategies adopted by players in the
biomaterials market from 2012 to 2015. Players adopted these strategies to
expand their product portfolios and customer base, and fortify their sales
channels. The key players that adopted this strategy are Royal DSM
(Netherlands), Wright Medical Technology, Inc. (U.S.), Carpenter Technology
Corporation (U.S.), Corbion N.V. (Netherlands), Covalon Technologies Ltd.
(Canada), Evonik Industries AG (Germany), Heraeus Medical Components, Inc.
(U.S), Noble Biomaterials, Inc. (U.S.), and Exactech, Inc. (U.S.)
Image Credit: Google
New
product launches accounted for 18% of the total key growth strategies adopted
by players in the biomaterials market from 2012 to 2015. Players adopted this
strategy to strengthen their existing product portfolios. Key players that
adopted this strategy are BASF SE (Germany), Invibio Ltd. (U.K.), Wright
Medical Technology, Inc. (U.S.), Evonik Industries AG (Germany), DePuy
Orthopaedics, Inc. (U.S.), Biomet, Inc. (U.S.), and Morgan Technical Ceramics
(U.K.).
Expansions accounted for 18% of the total number of
growth strategies adopted by players in the biomaterials market from 2012 to
2015. Players adopted this strategy to strengthen their networks, increase
their global presence, enhance customer experience, and improve relationships
with customers. The key players that adopted this strategy are Royal DSM
(Netherlands), BASF SE (Germany), Corbion N.V. (Netherlands), Evonik Industries
AG (Germany), Heraeus Medical Components, Inc. (U.S), Bayer AG (Germany),
Materion Corporation (U.S.), DENTSPLY International Inc. (U.S.), and Morgan
Technical Ceramics (U.K.).
Thus, acquisitions were adopted by the majority of
players in the biomaterials market to strengthen their product portfolio,
combine proprietary technologies in order to create a strong services portfolio
and capture the clientele of the acquired company.
